Clinical

Dataset Information

0

Evaluating the effect of bowel preparation plus oral Rifaximin in Brachytherapy for endometrial and cervical Cancer


ABSTRACT: Intervention 1: Intervention group: bowel preparation with polyethilenglycol and bisacodyl tablet since 24 hours befor trearment and also rifaximin 400 mg BD since 7 days befor treatment. Intervention 2: Control group: bowel preparation with polyethilenglycol and bisacodyl tablet since 24 hours befor trearment. Primary outcome(s): Rectal volume. Timepoint: Before(basement) and 7 days after oral Rifaximin. Method of measurement: HDR plus 3.0.8 brachytherapy , treatment planning, Bebig & Ziegler company.;Rectal Dose-volume parameters. Timepoint: Before(basement) and 7 days after oral Rifaximin. Method of measurement: HDR plus 3.0.8 brachytherapy treatment planning, Bebig & Ziegler company. Study Design: Randomization: Not randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Prevention.

DISEASE(S): Condition 1: Endometrial Cancer. Condition 2: Cervical Cancer,Malignant Neoplasm Of Cervix Uteri, Unspecified,Malignant Neoplasm Of Endometrium

PROVIDER: 2501076 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Similar Datasets

| 2484333 | ecrin-mdr-crc
| 24659 | ecrin-mdr-crc
| 2482659 | ecrin-mdr-crc
2024-09-12 | GSE268793 | GEO
| 2727544 | ecrin-mdr-crc
| 2488847 | ecrin-mdr-crc
2014-03-01 | E-GEOD-54476 | biostudies-arrayexpress
2014-03-01 | E-GEOD-54475 | biostudies-arrayexpress
| 2503026 | ecrin-mdr-crc
| 2475013 | ecrin-mdr-crc